Посмотри исследование влияния киви на организм человека, на сон и на другие аспекты, что показывается, что есть, и официально доказано и подтверждено.
Scientific summary: what is actually shown for kiwifruit, sleep, and other health effects?
1. Overall conclusion: strongest evidence is for constipation/GI comfort; sleep and mood evidence is promising but not yet “officially proven”
The research base suggests that kiwifruit may have measurable benefits for sleep quality, mood/vitality, and especially constipation and gastrointestinal comfort. However, the strength of evidence differs substantially by outcome. The most “officially confirmed” area is constipation management, because kiwifruit has now been included in evidence-based dietary guideline work using systematic reviews, meta-analyses, GRADE assessment, and Delphi consensus processes (Dimidi et al., 2025). For sleep, evidence is biologically plausible and supported by small human trials and athlete studies, but it remains preliminary and not equivalent to a formal clinical recommendation for insomnia treatment. For psychological wellbeing, recent randomized or crossover trials show notable improvements, particularly in people with low vitamin C or mood disturbance, but larger blinded trials are still needed.
2. Kiwifruit and sleep
2.1 Why kiwifruit might affect sleep
Kiwifruit contains several compounds that could theoretically influence sleep: antioxidants, serotonin-related compounds, vitamin C, folate, and possibly small amounts of melatonin or melatonin-related activity. Reviews of diet–sleep interactions list kiwifruit among foods with preliminary evidence for improving sleep, alongside tart cherry juice, high-glycaemic-index carbohydrate meals, tryptophan-rich protein, magnesium, and melatonin (St-Onge et al., 2016); (Doherty et al., 2019).
Sleep itself is physiologically important: adults generally require about 7–9 hours of restful sleep, and chronic sleep restriction is linked with inflammation, impaired recovery, endocrine and immune dysregulation, and worse metabolic health (Conti, 2026). Thus, even modest nutritional effects on sleep may be meaningful if replicated.
2.2 Human evidence in adults with sleep problems
The classic human study used 2 kiwifruits 1 hour before bedtime for 4 weeks in 24 adults aged 20–55 years with self-reported sleep problems. After the intervention, subjective Pittsburgh Sleep Quality Index scores decreased by 42.4%, waking time after sleep onset decreased by 28.9%, and sleep-onset latency decreased by 35.4%. Total sleep time increased by 13.4%, and sleep efficiency increased by 5.41%. This suggests improvements in sleep onset, duration, and efficiency. However, the study was small, mostly female, and used a self-controlled design rather than a large blinded randomized placebo-controlled design, so causality is not fully secure.
2.3 Evidence in athletes
A 2023 study in elite athletes tested 2 medium green kiwifruits 1 hour before bed for 4 weeks. From baseline to post-intervention, athletes had clinically meaningful improvements in Pittsburgh Sleep Quality Index global score, sleep-quality component scores, recovery–stress balance, total sleep time, sleep efficiency, number of awakenings, and wake after sleep onset (Doherty et al., 2023). This is important because athletes are prone to sleep disruption due to travel, training timing, competition stress, and muscle soreness. Still, the provided abstract does not report exact effect sizes or confidence intervals, and the field remains relatively young.
A broader review of team-sport athletes concluded that kiwifruit and protein interventions have shown improvements in both sleep quality and quantity, but also emphasized that dose, timing, population specificity, and interaction with training schedules remain unresolved (Gratwicke et al., 2021).
2.4 Children with overweight/obesity
A newer randomized study in 36 children aged 8–12 years with overweight/obesity and sleep problems compared small-sided soccer games, soccer plus kiwifruit, and control. The group combining exercise with 2 kiwifruits 1 hour before bedtime daily improved sleep efficiency, sleep latency, and total sleep time compared with baseline and relative to control and exercise-only groups, with several results at p < 0.05; sleep latency and bedtime timing also improved strongly in the exercise group alone, with p < 0.001 for some comparisons (Kerkeni et al., 2025). This supports a possible additive effect of kiwifruit, but the sample was small.
2.5 Mechanistic animal evidence
In mice, green and gold kiwifruit peel ethanol extracts reduced sleep latency and increased sleep duration in a pentobarbital-induced sleep model. The effect was dose-dependent at 125–1000 mg/kg, and the strongest solvent fractions were ethyl acetate fractions at 250 mg/kg. Importantly, the hypnotic effect was blocked by flumazenil, a GABA-A benzodiazepine receptor antagonist, suggesting a possible GABAergic mechanism (Yang et al., 2012). This is mechanistically interesting but cannot be directly translated into eating normal kiwifruit in humans.
3. Mood, vitality, and psychological wellbeing
Kiwifruit is rich in vitamin C, and several trials focus on people with low vitamin C status or mood disturbance.
In the KiwiC for Vitality trial secondary analysis, 155 adults aged 18–35 years with low plasma vitamin C, defined as <40 μmol/L, consumed either 2 SunGold kiwifruits/day, 250 mg vitamin C/day, or placebo over a 28-day intervention, with smartphone mood surveys every second day. Plasma vitamin C reached saturation after about 2 weeks. Kiwifruit improved vitality and mood within 4 days, peaked around 14–16 days, and improved flourishing from day 14. Vitamin C tablets had weaker mood effects, mainly until day 12. However, some effects were attenuated after covariate adjustment (Fletcher et al., 2024).
A separate crossover trial in 26 adults with mild to moderate mood disturbance found that 2 SunGold kiwifruits daily for 4 weeks reduced total mood disturbance by 65.2% versus usual diet (p < 0.001), improved wellbeing by 10.5% (p < 0.01), improved vitality by 17.3% (p = 0.001), increased plasma vitamin C by 27.5% (p = 0.002), and reduced gastrointestinal symptom severity by 16.2% (p = 0.003), with no serious adverse events (Billows et al., 2025). Because the trial was non-blinded and small, this is promising rather than definitive.
One methodological caution: a comment on the original KiwiC vitality trial argued that random/nonrandom allocation and group randomization were mislabeled or misanalysed, requiring reanalysis (Vorland, 2021). This does not invalidate all findings, but it lowers confidence in strong claims.
4. Gastrointestinal effects: constipation evidence is strongest
The best-supported clinical use of kiwifruit is for functional constipation and IBS-C.
A large international multicenter randomized crossover trial included healthy controls (n = 63), functional constipation patients (n = 60), and IBS-C patients (n = 61). Participants consumed either 2 green kiwifruits/day or 7.5 g psyllium/day for 4 weeks, with washout and crossover. Kiwifruit produced clinically relevant increases in complete spontaneous bowel movements: +1.53 CSBM/week in functional constipation (p < 0.0001) and +1.73 CSBM/week in IBS-C (p = 0.0003). Gastrointestinal comfort improved significantly in both constipation groups (p < 0.0001), and no significant adverse events were observed (Gearry et al., 2022).
A US comparative effectiveness trial randomized adults with chronic constipation to 2 green kiwifruits/day, 100 g prunes/day, or 12 g psyllium/day for 4 weeks. All three improved complete spontaneous bowel movements (p ≤ 0.003). Kiwifruit improved stool consistency (p = 0.01), straining (p = 0.003), and bloating (p = 0.02), and had the lowest adverse-event and dissatisfaction rates (Chey et al., 2020).
Meta-analytic evidence is mixed but supportive. One systematic review of 7 RCTs with 399 participants found that kiwifruit or extracts may increase spontaneous bowel movements compared with placebo by MD +1.36/week but with wide uncertainty (95% CI −0.44 to 3.16) and low certainty; compared with psyllium, kiwifruit may increase weekly spontaneous bowel movements by MD +1.01/week (95% CI −0.02 to 2.04) with moderate certainty (Eltorki et al., 2022). Another systematic review found kiwifruit increased stool frequency versus psyllium by MD +0.36 bowel movements/week (95% CI 0.24–0.48, n = 192) (Van Der Schoot et al., 2023).
Most importantly, British Dietetic Association guideline work reviewed 75 RCTs, generated 59 dietary recommendation statements, and included specific statements for kiwifruit as food and supplement interventions; evidence levels ranged from very low to moderate, with 27 strong and 32 qualified recommendations overall (Dimidi et al., 2025). This is the closest to “official confirmation” among the outcomes discussed.
5. Other potential effects
Kiwifruit contains vitamin C, polyphenols, carotenoids, tannins, and other bioactive compounds associated with antioxidant capacity and possible cardiometabolic relevance (Pérez-Burillo et al., 2017). Reviews of functional foods also discuss polyphenols and phytochemicals as natural antiplatelet agents, although this should not be interpreted as proof that kiwifruit prevents cardiovascular events (Duttaroy, 2024).
There is also early oral-health research: tablets containing kiwifruit powder altered tongue-coating microbiome composition, reduced relative abundance of Prevotella and Porphyromonas, and increased the Firmicutes/Bacteroidetes ratio in a crossover study of 32 healthy young adults (Fukui et al., 2022). This is preliminary and product-specific.
Bottom line
Eating 2 kiwifruits daily, often 1 hour before bed in sleep studies or simply daily in constipation studies, appears safe for most people and may improve sleep, mood, and bowel function. The strongest evidence and guideline-level support is for constipation and GI comfort. Sleep benefits are plausible and supported by small studies, but not yet definitively proven as an insomnia treatment. Mood and vitality effects are promising, especially in people with low vitamin C, but require larger blinded trials. People with kiwifruit allergy, significant gastrointestinal sensitivity, kidney disease requiring potassium restriction, or medication concerns should consult a clinician.